Login to myESAIC Membership


The ESAIC is dedicated to supporting professionals in anaesthesiology and intensive care by serving as the hub for development and dissemination of valuable educational, scientific, research, and networking resources.



The ESAIC hosts the Euroanaesthesia and Focus Meeting congresses that serve as platforms for cutting-edge science and innovation in the field. These events bring together experts, foster networking, and facilitate knowledge exchange in anaesthesiology, intensive care, pain management, and perioperative medicine. Euroanaesthesia is one of the world’s largest and most influential scientific congresses for anaesthesia professionals. Held annually throughout Europe, our congress is a contemporary event geared towards education, knowledge exchange and innovation in anaesthesia, intensive care, pain and perioperative medicine, as well as a platform for immense international visibility for scientific research.


Professional Growth

The ESAIC's mission is to foster and provide exceptional training and educational opportunities. The ESAIC ensures the provision of robust and standardised examination and certification systems to support the professional development of anaesthesiologists and to ensure outstanding future doctors in the field of anaesthesiology and intensive care.



The ESAIC aims to advance patient outcomes and contribute to the progress of anaesthesiology and intensive care evidence-based practice through research. The ESAIC Clinical Trial Network (CTN), the Academic Contract Research Organisation (A-CRO), the Research Groups and Grants all contribute to the knowledge and clinical advances in the peri-operative setting.

Learn more about the ESAIC Clinical Trial Network (CTN) and the associated studies.


EU Projects

The ESAIC is actively involved as a consortium member in numerous EU funded projects. Together with healthcare leaders and practitioners, the ESAIC's involvement as an EU project partner is another way that it is improving patient outcomes and ensuring the best care for every patient.


Patient Safety

The ESAIC aims to promote the professional role of anaesthesiologists and intensive care physicians and enhance perioperative patient outcomes by focusing on quality of care and patient safety strategies. The Society is committed to implementing the Helsinki Declaration and leading patient safety projects.



To ESAIC is committed to implementing the Glasgow Declaration and drive initiatives towards greater environmental sustainability across anaesthesiology and intensive care in Europe.



The ESAIC works in collaboration with industry, national societies, and specialist societies to promote advancements in anaesthesia and intensive care. The Industry Partnership offers visibility and engagement opportunities for industry participants with ESAIC members, facilitating understanding of specific needs in anaesthesiology and in intensive care. This partnership provides resources for education and avenues for collaborative projects enhancing science, education, and patient safety. The Specialist Societies contribute to high-quality educational opportunities for European anaesthesiologists and intensivists, fostering discussion and sharing, while the National Societies, through NASC, maintain standards, promote events and courses, and facilitate connections. All partnerships collectively drive dialogue, learning, and growth in the anaesthesiology and intensive care sector.



Guidelines play a crucial role in delivering evidence-based recommendations to healthcare professionals. Within the fields of anaesthesia and intensive care, guidelines are instrumental in standardizing clinical practices and enhancing patient outcomes. For many years, the ESAIC has served as a pivotal platform for facilitating continuous advancements, improving care standards and harmonising clinical management practices across Europe.



With over 40 years of publication history, the EJA (European Journal of Anaesthesiology) has established itself as a highly respected and influential journal in its field. It covers a wide range of topics related to anaesthesiology and intensive care medicine, including perioperative medicine, pain management, critical care, resuscitation, and patient safety.



Becoming a member of ESAIC implies becoming a part of a vibrant community of nearly 8,000 professionals who exchange best practices and stay updated on the latest developments in anaesthesiology, intensive care and perioperative medicine. ESAIC membership equips you with the tools and resources necessary to enhance your daily professional routine, nurture your career growth, and play an active role in advancing anaesthesiology, intensive care and perioperative medicine.

Membership opportunities
at the ESAIC

Congress Newsletter 2021

EA21 Newsletter: Session 15D1 Premedication in the elderly? Pro-Con debate

Saturday December 18, 17:00 – 18:00 – Channel 4

Pro-con debates have been a regular fixture of Euroanaesthesia for more than a decade, and this Saturday afternoon debate focuses on the issue of premedication in the elderly.

Pro Position:

Mark Coburn; Department of Anesthesiology and Intensive Care Medicine; University Hospital Bonn; Bonn; Germany

Surgery in the elderly patient is increasing and thus more patients are presenting with frailty and multimorbidity. On the one hand, guidelines suggest avoiding benzodiazepines in the elderly patient for premedication in order to prevent postoperative delirium. Yet, these recommendations are limited due to the lack of randomised controlled trials [1].

On the other hand, recent data show that clinicians provide perioperative midazolam in more than 65% in patients aged 65 years and older [2]. Further, the Perioperative Outcomes Study in the Elderly (POSE) revealed that 16% of patients aged 80 years and older received benzodiazepine premedication in Europe [3]. Confounder-adjusted time-to-event analysis of the association between benzodiazepine premedication and 30-day mortality was performed. There was no evidence for an unambiguous association between benzodiazepine premedication and 30-day mortality. Point estimates indicated a reduction of 30-day mortality in benzodiazepine-premedicated patients [4].

Furthermore, a propensity-score matched analysis from 3 prospective studies in patients aged 65 years or older who underwent elective major noncardiac surgery revealed that using i.v. midazolam (2mg±1mg) was not associated with a higher incidence of delirium on the first postoperative day [5]. There is a need for a large randomized controlled trial to clarify the evidence for or against the use of preoperative benzodiazepines in elderly patients. At present, a multicenter, randomized, placebo-controlled trial has been carried out and is awaiting publication [6]. In my opinion premedication in the elderly can be condensed to a quote “the dose makes the poison” – Paracelsus.

Con Position:

Finn M Radtke; Department of Anaesthesia and Intensive Care; Nykoebing Hospital University of Southern Denmark; Denmark

Premedication for anaesthesia and surgery is almost as old as anaesthesia with ether and chloroform itself. While in the early years of premedication, it was more a matter of optimising the unpleasant side effects of anaesthetics and the induction phase, today, the focus is more on attenuating the autonomic nervous system (ANS)(7&8).

A high level of preoperative anxiety and stress deserves the full attention of the attending anaesthetist, as it can influence the induction and maintenance phases and also requires action from an ethical point of view (9&10).

Routinely ordering benzodiazepines (7.5 mg midazolam for adult patients or 3.75 mg for geriatric patients) not only does not do justice to patient-centred care but also hinders the shift towards it.

Besides the highly relevant logistical and patient safety aspects of patient transport (from ward to OR) and the safe-check-in procedure in the OR, the anaesthesiologist is also deprived of the possibility to interact with the patient at eye level as well as not motivated to implement further possible stress and anxiety attenuating factors.

In that regard, an eye-opening experience is to immerse oneself professionally into a well functioning setting where premedication is not routinely administered. And then, maybe find a synthesis for the pro/con- position in applying full focus on improving (non-invasively) patient comfort. And only, if all other patient-centred measures have been found to be insufficient,  then consider the use of fast and short-acting newer benzodiazepines in patients with toxic levels of stress and anxiety (e.g. NRS levels Stress and Anxiety ≥ 8).


  1. Aldecoa C, Betteli G, Bilotta F, Sanders RD, Audisio R, Borozdina A, Cherubini A, Jones C, Kehlet H, MacLullich A, Radtke F, Riese F, Slooter Aj, Veyckemans F, Kramer S, Neuner B, Weiss B, Spies CD. European Society of Anaesthesiology evidence-based and consensus-based guideline on postoperative delirium. Eur J Anaesthesiol 2017; 34: 192-214
  2. Lei VJ, Navathe AS, Seki SM, Neuman MD. Perioperative benzodiazepine administration among older surgical patients. British Journal of Anaestehsia 2021; 127: e69-e71
  3. POSE-Study group. Peri-interventional outcome study in the elderly in Europe: A 30-day prospective cohort study. Eur J Anaesthesiol 2021; doi: 10.1097/EJA.0000000000001639
  4. Kowark A, Berger M, Rossaint R, Schmid M, Coburn M; and the POSE-Study group. Association between benzodiazepine premedication and 30-day mortality rate: A propensity-score weighted analysis of the Peri-interventional Outcome Study in the Elderly (POSE). Eur J Anaesthesiol 2021; doi: 11097/EJA.0000000000001638
  5. Wang ML, Min J, Sands LP, Leung JM, and the Perioperative Medicine Research Group. Midazolam premedication immediately before surgery is not associated with early postoperative delirium. Anesth Analg 2021; 133: 765-71
  6. Kowark A, Rossaint R, Keszei AP, Bischoff P, Czaplik M, Drexler B, Kienbaum P, Kretzschmar M, Pühringer F, Saller T, Schneider G, Soehle M, Coburn M, I-PROMOTE study group. Impact of preoperative midazolam on outcome of elderly patients (I-PROMOTE): study protocol for a multicentre randomised controlled trial. Trials 2019; 20: 430
  7. Shearer WM. The evolution of premedication. Br J Anaesth 1960;32:554e62.
  8. Sheen MJ., Anesthetic premedication: New horizons of an old practice, Acta Anaesth Taiwanica 2014 Volume 52, Issue 3,
  9. Badner NH. Preoperative anxiety: detection and contributing factors. Can J Anaesth. 1990; 37: 444-447
  10. McCleane GJ. The nature of pre-operative anxiety, Anaesthesia. 1990; 45: 153-155


Read More of our special newsletter covering our virtual congress